Cargando…
Clinical outcomes of using remdesivir in patients with moderate to severe COVID-19: A prospective randomised study
BACKGROUND AND AIMS: When the world was frantically searching for a drug effective against the coronavirus disease (COVID)-19, remdesivir, a broad-spectrum anti-viral medication, became a part of the COVID treatment. We planned a study to evaluate improvement in clinical outcomes with remdesivir tre...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993042/ https://www.ncbi.nlm.nih.gov/pubmed/33814589 http://dx.doi.org/10.4103/ija.IJA_149_21 |